Shanghai, China

Mei Ge

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Innovations of Mei Ge in the Field of Glycopeptide Compounds

Introduction

Mei Ge is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in developing glycopeptide compounds that combat drug-resistant bacteria. His innovative work addresses a critical need in modern medicine, especially in the face of increasing antibiotic resistance.

Latest Patents

Mei Ge holds a patent for glycopeptide compounds that exhibit activity against drug-resistant bacteria. The patent, titled "Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof," reveals compounds represented by a general formula. The invention provides a preparation method and application for these glycopeptide compounds. Testing has shown that these compounds have superior inhibition activity against drug-resistant strains, particularly MRSA and VRE, compared to the second-generation glycopeptide drug oritavancin. Furthermore, many of these compounds demonstrate a safety profile that exceeds that of oritavancin, making them suitable for developing drugs to treat various bacterial infections, including skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema. Mei Ge's patent portfolio includes 1 patent.

Career Highlights

Throughout his career, Mei Ge has worked with notable companies in the biopharmaceutical sector. He has been associated with Shanghai Laiyi Center for Biopharmaceutical R&D Co., Ltd. and Zhejiang Medicine Co., Ltd. His work in these organizations has contributed to advancing research and development in the field of drug resistance.

Collaborations

Mei Ge has collaborated with several professionals in his field, including Chang Shao and Lingao Ruan. These collaborations have fostered innovation and enhanced the development of effective treatments against bacterial infections.

Conclusion

Mei Ge's contributions to the field of glycopeptide compounds represent a significant advancement in the fight against drug-resistant bacteria. His innovative research and patent holdings underscore the importance of continued exploration in biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…